Stroke Trial, Recruiting NCT05957354 Sponsor: Changping Laboratory Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05957354
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 35 and 75 years old (inclusive).
  • People who have been diagnosed with either an ischemic stroke (a blockage-type stroke) or a hemorrhagic stroke (a bleeding-type stroke), where the stroke affected the left side of the brain, and where the stroke occurred between 15 days and 6 months ago.
  • People who have been assessed as having aphasia (difficulty with language and communication after stroke) using a standardised Chinese-language test called the Western Aphasia Battery, with a score below 93.8.
  • People experiencing their first-ever stroke.
  • People whose language skills were normal before their stroke, whose first language is Chinese, and who have had at least 6 years of education.
  • People who understand the trial and have signed a consent form agreeing to take part.

Who may not be able to join:

  • People who also have dysarthria, a separate speech muscle condition, measured at a certain severity on a standard stroke scale (confirm with trial site).
  • People whose aphasia was caused by a stroke affecting both sides of the brain, or by a brain tumour, head injury, Parkinson's disease, motor neuron disease, or another condition.
  • People who have an implanted electronic device such as a pacemaker or cochlear implant, any metal implants in the body, a fear of enclosed spaces (claustrophobia), or any other reason they cannot safely have an MRI scan or a brain stimulation treatment called TMS.
  • People with a history of epilepsy.
  • People with serious ongoing conditions affecting the heart, lungs, liver, kidneys, or other major organs that are not controlled by standard medications.
  • People with reduced or impaired consciousness, as measured by a standard stroke assessment scale (confirm with trial site).
  • People with severely high blood pressure that is difficult to control (malignant hypertension).
  • People with a serious illness such as cancer where life expectancy is estimated to be less than one year.
  • People with severe hearing loss, severe vision problems, significant cognitive (thinking and memory) difficulties, or who are otherwise unable to participate in the trial activities.
  • People with severe depression, severe anxiety, or another diagnosed mental health condition that would prevent them from completing the trial.
  • People who have received brain stimulation treatments — such as TMS or transcranial electrical stimulation — within the 3 months before enrolling.
  • People with a history of alcohol dependence, drug abuse, or other substance abuse.
  • People whom the research team considers unsuitable for the trial based on other findings.
  • People who would be unable to attend follow-up appointments due to where they live or other practical reasons.
  • People who are pregnant, breastfeeding, or planning to become pregnant (or for whom pregnancy is possible) during the trial period.
  • People who are currently taking part in another clinical trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hesheng Liu, PhD, Changping Laboratory

Phone: 010-80726688

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Changping Laboratory
Registry
ClinicalTrials.gov
Start date
28 July 2023
Est. completion
1 August 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in the Western Aphasia Battery scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov